genau wie bei DNAP? - 500 Beiträge pro Seite

[morchel]

RGII, eine shell, gab heute bekannt:

Monday July 30, 9:25 am Eastern Time
Press Release
SOURCE: Regent Group
Regent Group Merges With Millennium Biotechnologies
BERNARDSVILLE, N.J., July 30 /PRNewswire/ -- Millennium Biotechnologies, Inc. -- a new research-based bio-nutraceutical company and a pioneer in the emerging field of nutritional science -- has merged with Regent Group, Inc. (OTC Bulletin Board: RGII - news).

As a result of the merger, Millennium Biotechnologies stockholders received Regent preferred stock convertible into approximately 95 percent of the outstanding common stock of Regent Group. Jerry Swon, President/Chief Executive officer of Millennium Biotechnologies has become President/Chief Executive Officer of Regent Group.

``This merger will allow Millennium Biotechnologies to expand its research and development efforts,`` said Swon. ``Our strategy is to bring to market cutting-edge nutraceutical products that change the face of nutritional science.``

The merger coincides with Millennium Biotechnologies` planned new product launch of RESURGEX(TM), an innovative nutraceutical supplement. This product serves as important nutritional support for immuno-compromised individuals undergoing medical treatment for chronic debilitating diseases that cause tissue wasting (weight loss), oxidative stress (free-radical damage) and mitochondrial failure (fatigue/low energy). RESURGEX(TM) combines three nutritional therapies with an advanced micro- and macro-nutrient base into a single, potent and delicious nutritional supplement. The Company believes that the product`s innovative multi-component approach to supporting the immune function can help to reduce oxidative stress, maintain lean muscle and increase energy. RESURGEX(TM), a powder supplement drink, is available in easy-to-use, convenient single-serving 8 oz. bottles -- just add water, juice or milk, shake and enjoy.

Millennium Biotechnologies owns a series of nutraceutical formulas based on proprietary combinations of nutritional base ingredients. The Company headquarters are located in Bernardsville, N.J.

This release includes certain forward-looking information that is based upon management`s beliefs as well as on assumptions made by and data currently available to management. This information which has been, or in the future may be, included in reliance on the ``safe harbor`` provisions on the Private Securities Litigation Reform Act of 1995, is subject to a number of risks and uncertainties, including but not limited to the factors identified in the Company`s 10-KSB and other documents filed with the Securities and Exchange Commission. Actual results may differ materially from those anticipated in such forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein may not be realized. The Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.

SOURCE: Regent Group

Zwar nicht so spektakuläre Aussichten wie bei DNAP, aber ein immens kleiner Freefloat und sehr geringe Marktkapitalisierung!

Weiteres Research folgt morgen


Shares Outstanding 5.48M
Float 500.0
Marktkapitalisierung unter 1 Mil

morchel
http://www.zockstocks.com Newsletterbezieher wissen es bereits!

[morchel]

Wie versprochen!

Homepage: http://www.milbiotech.com

Ich hab ihnen mal gemailt, mal sehen, ob und was zurückkommt!

morchel

[witchdoctor]

heute geht was !

Viel Glück

[RSA]

Hi



Schade,binn zu früh ausgestiegen.
Whäre ja einer nette zock gewesen.
Nächstes mal verleicht.

RSA

[morchel]

...das waren immerhin ein plus von 175% in der vergangenen Woche!

Dankesschreiben werden mit Zustimmung veröffentlicht!

morchel